Dong Yu
Corporate Officer/Principal bei DYNAVAX TECHNOLOGIES CORPORATION
Ursprung des Netzwerks ersten Grades von Dong Yu
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dong Yu
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer | |
| LANCER ORTHODONTICS, INC. | Medical Specialties | Director/Board Member | |
| VIVUS, INC. | Pharmaceuticals: Major | General Counsel | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| SANOFI | Biotechnology | Corporate Officer/Principal | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman | |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
| San Diego State University | College/University | Undergraduate Degree | |
| The California State University | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| North Carolina State University | College/University | Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| Wellesley College | College/University | Undergraduate Degree | |
Centers for Disease Control & Prevention
 Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | General Government | Corporate Officer/Principal | |
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Medical Specialties | General Counsel | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
Evercore Capital Partners
 Evercore Capital Partners Investment ManagersFinance Evercore Capital Partners (Evercore Capital) is a private equity subsidiary of Evercore Group LLC founded in 1996 by Roger C. Altman. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin | |
| The Santa Clara University School of Law | College/University | Graduate Degree | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
| University of Vermont College of Medicine | College/University | Doctorate Degree | |
| VAXCYTE, INC. | Biotechnology | Director of Finance/CFO | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Internet Software/Services | Director of Finance/CFO | |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 42 |
| Frankreich | 3 |
| Schweden | 3 |
| Kanada | 3 |
| Belgien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 3 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 63 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 30 |
| Undergraduate Degree | 23 |
| Director of Finance/CFO | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Dan Kisner | 29 |
| Andrew Hack | 20 |
| Scott Myers | 18 |
| Julia Eastland | 16 |
| Francis Cano | 13 |
| Elaine Sun | 10 |
| Jeff P. Coon | 10 |
| Peggy Phillips | 9 |
| Paul Cox | 9 |
| Alex Oh | 8 |
| Brent MacGregor | 8 |
| David Novack | 7 |
| Michael S. Ostrach | 7 |
| John L. Slebir | 6 |
| Robert Janssen | 5 |
